ANNEX IX GERMINAL PRODUCTS OF BOVINE ANIMALS, Regulation (EU) 2021/404

In forcesince 8 Jan 2025cited 5×

ISO code and name

of the third country or territory

Code of the zone

as set out in Part 2

Categoriesof germinal products

permitted to enter the Union

Animal health certificates |

Specific conditions

as set out in Part 3

Animal health guarantees

as set out in Part 4

1 | 2 | 3 | 4 | 5 | 6

AR

Argentina

AR-0 | Oocytes and embryos |

BOV-OOCYTES-EMB-A-ENTRY

BOV-in-vivo-EMB-B-ENTRY

BOV-in-vitro-EMB-C-ENTRY

BOV-in-vitro-EMB-D-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

AU

Australia

AU-0 | Semen |

BOV-SEM-A-ENTRY

BOV-SEM-B-ENTRY

BOV-SEM-C-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

EHD-test

BTV-test

Oocytes and embryos |

BOV-OOCYTES-EMB-A-ENTRY

BOV-in-vivo-EMB-B-ENTRY

BOV-in-vitro-EMB-C-ENTRY

BOV-in-vitro-EMB-D-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

EHD-test

BTV-test

CA

Canada

CA-0 | Semen | Commission Decision 2005/290/EC | |

SF-BTV

SF-EHD

EHD-test

BTV-test

Oocytes and embryos |

BOV-OOCYTES-EMB-A-ENTRY

BOV-in-vivo-EMB-B-ENTRY

BOV-in-vitro-EMB-C-ENTRY

BOV-in-vitro-EMB-D-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

SF-BTV

SF-EHD

EHD-test

BTV-test

CH

Switzerland

CH - 0 | Semen | Subject to the Agreement referred to in point 7 of Annex I |

Oocytes and embryos

CL

Chile

CL - 0 | Semen |

BOV-SEM-A-ENTRY

BOV-SEM-B-ENTRY

BOV-SEM-C-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

GB

United Kingdom

GB-1 | Semen |

BOV-SEM-A-ENTRY

BOV-SEM-B-ENTRY

BOV-SEM-C-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

Period before 1 January 2021 |

BRU

EBL

BTV-test

Oocytes and embryos |

BOV-OOCYTES-EMB-A-ENTRY

BOV-in-vivo-EMB-B-ENTRY

BOV-in-vitro-EMB-C-ENTRY

BOV-in-vitro-EMB-D-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

Period before 1 January 2021

GB-2 | Semen |

BOV-SEM-A-ENTRY

BOV-SEM-B-ENTRY

BOV-SEM-C-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

Period before 1 January 2021 |

BRU

TB

EBL

BTV-test

Oocytes and embryos |

BOV-OOCYTES-EMB-A-ENTRY

BOV-in-vivo-EMB-B-ENTRY

BOV-in-vitro-EMB-C-ENTRY

BOV-in-vitro-EMB-D-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

Period before 1 January 2021

GG

Guernsey

GG-0 | Semen |

BOV-SEM-A-ENTRY

BOV-SEM-B-ENTRY

BOV-SEM-C-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

Period before 1 January 2021 |

Oocytes and embryos |

BOV-OOCYTES-EMB-A-ENTRY

BOV-in-vivo-EMB-B-ENTRY

BOV-in-vitro-EMB-C-ENTRY

BOV-in-vitro-EMB-D-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

Period before 1 January 2021 |

GL

Greenland

GL - 0 | Semen |

BOV-SEM-A-ENTRY

BOV-SEM-B-ENTRY

BOV-SEM-C-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

IL

Israel

IL-0 | Oocytes and embryos |

BOV-OOCYTES-EMB-A-ENTRY

BOV-in-vivo-EMB-B-ENTRY

BOV-in-vitro-EMB-C-ENTRY

BOV-in-vitro-EMB-D-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

IS

Iceland

IS-0 | Semen |

BOV-SEM-A-ENTRY

BOV-SEM-B-ENTRY

BOV-SEM-C-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

IM

Isle of Man

IM-0 | Semen |

BOV-SEM-A-ENTRY

BOV-SEM-B-ENTRY

BOV-SEM-C-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

Period before 1 January 2021 |

BRU

TB

EBL

Oocytes and embryos |

BOV-OOCYTES-EMB-A-ENTRY

BOV-in-vivo-EMB-B-ENTRY

BOV-in-vitro-EMB-C-ENTRY

BOV-in-vitro-EMB-D-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

Period before 1 January 2021

JE

Jersey

JE-0 | Semen |

BOV-SEM-A-ENTRY

BOV-SEM-B-ENTRY

BOV-SEM-C-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

Period before 1 January 2021 | EBL

Oocytes and embryos |

BOV-OOCYTES-EMB-A-ENTRY

BOV-in-vivo-EMB-B-ENTRY

BOV-in-vitro-EMB-C-ENTRY

BOV-in-vitro-EMB-D-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

Period before 1 January 2021

MK

North Macedonia

MK-0 | Oocytes and embryos |

BOV-OOCYTES-EMB-A-ENTRY

BOV-in-vivo-EMB-B-ENTRY

BOV-in-vitro-EMB-C-ENTRY

BOV-in-vitro-EMB-D-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

BTV-test

NZ

New Zealand

NZ-0 | Semen |

BOV-SEM-A-ENTRY

BOV-SEM-B-ENTRY

BOV-SEM-C-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

TB, BRU, BTV

Oocytes and embryos |

Annex I to Commission Implementing Decision (EU) 2015/1901

BOV-OOCYTES-EMB-A-ENTRY

BOV-in-vivo-EMB-B-ENTRY

BOV-in-vitro-EMB-C-ENTRY

BOV-in-vitro-EMB-D-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

TB, BRU, BTV

PM

Saint Pierre et Miquelon

PM-0 | Semen |

BOV-SEM-A-ENTRY

BOV-SEM-B-ENTRY

BOV-SEM-C-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

US

United States

US-0 | Semen |

BOV-SEM-A-ENTRY

BOV-SEM-B-ENTRY

BOV-SEM-C-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

EHD-test

BTV-test

Oocytes and embryos |

BOV-OOCYTES-EMB-A-ENTRY

BOV-in-vivo-EMB-B-ENTRY

BOV-in-vitro-EMB-C-ENTRY

BOV-in-vitro-EMB-D-ENTRY

BOV-GP-PROCESSING-ENTRY

BOV-GP-STORAGE-ENTRY

EHD-test

BTV-test

Name of the third country or territory | Code of the zone | Description of the zone

United Kingdom | GB-1 | England and Wales

GB-2 | Scotland

[Commission Implementing Regulation (EU) 2021/403 of 24 March 2021 laying down rules for the application of Regulations (EU) 2016/429 and (EU) 2017/625 of the European Parliament and of the Council as regards model animal health certificates and model animal health/official certificates, for the entry into the Union and movements between Member States of consignments of certain categories of terrestrial animals and germinal products thereof, official certification regarding such certificates and repealing Decision 2010/470/EU (OJ L 113, 31.3.2021, p. 1).]

Period before 1 January 2021 | The model certificates to be used for entry into the Union of semen, oocytes and embryos from the zone referred to in column 2 of the table set out in Part 1 collected or produced, processed and stored before 1 January 2021 are set out in Chapters 24, 25, 27, 28 and 29 of Annex I to Commission Implementing Regulation (EU) 2021/403

EHD-test | Compulsory testing for infection with epizootic haemorrhagic disease virus – consignments of semen, in vitro produced embryos and oocytes

BTV-test | Compulsory testing for infection with bluetongue virus– consignments of semen, in vitro produced embryos and oocytes

BRU | The Union has recognised freedom from infection with Brucellaabortus, B. melitensis and B. suis of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Implementing Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692

TB | The Union has recognised freedom from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae, M. tuberculosis) of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Implementing Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692

BTV | The Union has recognised freedom from infection with bluetongue virus (serotypes 1-24) of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692

SF-BTV | The Union has recognised seasonal freedom from infection with bluetongue virus (serotypes 1-24) of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Implementing Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692

SF-EHD | The Union has recognised seasonal freedom from infection with epizootic haemorrhagic disease virus of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692

EBL | The Union has recognised freedom from enzootic bovine leukosis of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692